Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses

被引:73
|
作者
Chen, Jie [1 ]
Harding, Shane M. [1 ,7 ]
Natesan, Ramakrishnan [1 ]
Tian, Lei [1 ]
Benci, Joseph L. [2 ,3 ,4 ,5 ,8 ]
Li, Weihua [1 ]
Minn, Andy J. [2 ,3 ,4 ,5 ]
Asangani, Irfan A. [1 ,5 ,6 ]
Greenberg, Roger A. [1 ]
机构
[1] Univ Penn, Penn Ctr Genome Integr, Basser Ctr BRCA, Perelman Sch Med,Dept Canc Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA
[7] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Biophys, Toronto, ON M5G 1L7, Canada
[8] Bristol Myers Squibb, Princeton, NJ 08540 USA
来源
CELL REPORTS | 2020年 / 32卷 / 09期
关键词
NUCLEAR-ENVELOPE RUPTURE; INDUCIBLE GENE-I; CYTOSOLIC DNA; CANCER; CGAS; RADIATION; ACTIVATION; PATHWAY; ATM; MECHANISMS;
D O I
10.1016/j.celrep.2020.108080
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The DNA-dependent pattern recognition receptor, cGAS (cyclic GMP-AMP synthase), mediates communication between the DNA damage and the immune responses. Mitotic chromosome missegregation stimulates cGAS activity; however, it is unclear whether progression through mitosis is required for cancercell-intrinsic activation of anti-tumor immune responses. Moreover, it is unknown whether cell cycle checkpoint disruption can restore responses in cancer cells that are recalcitrant to DNAdamage-induced inflammation. Here, we demonstrate that prolonged cell cycle arrest at the G(2)-mitosis boundary from either excessive DNA damage or CDK1 inhibition prevents inflammatory-stimulated gene expression and immune-mediated destruction of distal tumors. Remarkably, DNAdamage-induced inflammatory signaling is restored in a RIG-I-dependent manner upon concomitant disruption of p53 and the G(2) checkpoint. These findings link aberrant cell progression and p53 loss to an expanded spectrum of damage-associated molecular pattern recognition and have implications for the design of rational approaches to augment anti-tumor immune responses.
引用
收藏
页数:19
相关论文
共 15 条
  • [2] Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses
    Rossi, Alessandra
    Belmonte, Beatrice
    Carnevale, Silvia
    Liotti, Antonietta
    De Rosa, Veronica
    Jaillon, Sebastien
    Piconese, Silvia
    Tripodo, Claudio
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [3] Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope
    Tumenjargal, S
    Gellrich, S
    Linnemann, T
    Muche, JM
    Lukowsky, A
    Audring, H
    Wiesmüller, KH
    Sterry, W
    Walden, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) : 3175 - 3185
  • [4] Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses
    Joshi, Nikhil S.
    Akama-Garren, Elliot H.
    Lu, Yisi
    Lee, Da-Yae
    Chang, Gregory P.
    Li, Amy
    DuPage, Michel
    Tammela, Tuomas
    Kerper, Natanya R.
    Farago, Anna F.
    Robbins, Rebecca
    Crowley, Denise M.
    Bronson, Roderick T.
    Jacks, Tyler
    IMMUNITY, 2015, 43 (03) : 579 - 590
  • [5] Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor
    Wang, Ce
    Huang, Xue
    Wu, Yingjuan
    Wang, Jingbo
    Li, Furong
    Guo, Guoqing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (04): : 633 - 643
  • [6] Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
    Junko Matsuzaki
    Takemasa Tsuji
    Immanuel F. Luescher
    Hiroshi Shiku
    Junichi Mineno
    Sachiko Okamoto
    Lloyd J. Old
    Protul Shrikant
    Sacha Gnjatic
    Kunle Odunsi
    Scientific Reports, 5
  • [7] Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
    Matsuzaki, Junko
    Tsuji, Takemasa
    Luescher, Immanuel F.
    Shiku, Hiroshi
    Mineno, Junichi
    Okamoto, Sachiko
    Old, Lloyd J.
    Shrikant, Protul
    Gnjatic, Sacha
    Odunsi, Kunle
    SCIENTIFIC REPORTS, 2015, 5
  • [8] Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity
    Hodge, JW
    Grosenbach, DW
    Schlom, J
    CANCER DETECTION AND PREVENTION, 2002, 26 (04): : 275 - 291
  • [9] TSG-6+cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer
    Anandhan, Swetha
    Herbrich, Shelley
    Goswami, Sangeeta
    Guan, Baoxiang
    Chen, Yulong
    Macaluso, Marc Daniel
    Jindal, Sonali
    Natarajan, Seanu Meena
    Andrewes, Samuel W.
    Xiong, Liangwen
    Nagarajan, Ashwat
    Basu, Sreyashi
    Tang, Derek Ng
    Liu, Jielin
    Min, Jimin
    Maitra, Anirban
    Sharma, Padmanee
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [10] Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo
    Brunner, C
    Seiderer, J
    Schlamp, A
    Bidlingmaier, M
    Eigler, A
    Haimerl, W
    Lehr, HA
    Krieg, AM
    Hartmann, G
    Endres, S
    JOURNAL OF IMMUNOLOGY, 2000, 165 (11): : 6278 - 6286